Pangaea Oncology SA
MAD:PANG

Watchlist Manager
Pangaea Oncology SA Logo
Pangaea Oncology SA
MAD:PANG
Watchlist
Price: 1.68 EUR -1.18% Market Closed
Market Cap: 57.8m EUR
Section:
 

Relative Value

The Relative Value of one PANG stock under the Base Case scenario is hidden EUR. Compared to the current market price of 1.68 EUR, Pangaea Oncology SA is hidden .

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

PANG Relative Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Valuation Multiples

3.8
P/S
P/S
Price to Sales
3.8
vs History
98
vs Industry
25
Median 3Y
6
Median 5Y
7.6
Industry
4
Forward
3.4
More Details
Negative
P/E
P/E
Price to Earnings
N/A
vs History
vs Industry
Median 3Y
-18.8
Median 5Y
-24.3
Industry
32
Forward
-20.4
More Details
Negative
P/OCF
P/OCF
Price to OCF
N/A
vs History
vs Industry
Median 3Y
-13.6
Median 5Y
-15.6
Industry
19.8
More Details
Negative
P/FCFE
P/FCFE
Price to FCFE
N/A
vs History
vs Industry
Median 3Y
-10.5
Median 5Y
-9.8
Industry
27.6
More Details
2.8
P/B
P/B
Price to Book Value
2.8
vs History
41
vs Industry
33
Median 3Y
2.7
Median 5Y
2.7
Industry
2.8
More Details
3.8
EV/S
EV/S
Enterprise Value to Sales
3.8
vs History
96
vs Industry
22
Median 3Y
5.7
Median 5Y
7.3
Industry
4
Forward
3.4
More Details
5.8
EV/GP
EV/GP
Enterprise Value to Gross Profit
5.8
vs History
95
vs Industry
25
Median 3Y
10.6
Median 5Y
9.2
Industry
9
More Details
124.2
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
124.2
vs History
9
vs Industry
Median 3Y
-32.4
Median 5Y
24
Industry
19.8
Forward
-22.2
More Details
Negative
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
N/A
vs History
vs Industry
Median 3Y
-19.3
Median 5Y
-24.2
Industry
24.5
Forward
-22.2
More Details
Negative
EV/OCF
EV/OCF
Enterprise Value to OCF
N/A
vs History
vs Industry
Median 3Y
-12.5
Median 5Y
-13.7
Industry
20.3
More Details
Negative
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
N/A
vs History
vs Industry
Median 3Y
-11.5
Median 5Y
-13.6
Industry
27.3
More Details
2.2
EV/IC
EV/IC
Enterprise Value to IC
2.2
vs History
44
vs Industry
41
Median 3Y
2.2
Median 5Y
2.2
Industry
2.3
More Details

Multiples Across Competitors

PANG Competitors Multiples
Pangaea Oncology SA Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
ES
Pangaea Oncology SA
MAD:PANG
57.3m EUR 3.8 -45.5 124.2 -25.6
US
PerkinElmer Inc
LSE:0KHE
1.1T USD 376.3 4 457.5 1 370.2 2 893
US
Thermo Fisher Scientific Inc
NYSE:TMO
215.1B USD 4.9 32.7 23.4 30.2
US
Danaher Corp
NYSE:DHR
159.4B USD 6.6 45.5 24.4 36.9
CH
Lonza Group AG
SIX:LONN
35.6B CHF 5 48.5 37.1 37.1
US
Agilent Technologies Inc
NYSE:A
39.3B USD 5.7 30.2 23.3 27.8
US
IQVIA Holdings Inc
NYSE:IQV
38.2B USD 2.4 29.8 14.5 21.7
CN
WuXi AppTec Co Ltd
SSE:603259
259.1B CNY 5.8 17.3 19.7 19.7
KR
Samsung Biologics Co Ltd
KRX:207940
45.1T KRW 8.2 28.3 16.5 21.9
US
Mettler-Toledo International Inc
NYSE:MTD
28.4B USD 7.2 34 24.5 27.2
FR
Sartorius Stedim Biotech SA
PAR:DIM
19.7B EUR 6.7 74.5 26.5 43.6
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
ES
Pangaea Oncology SA
MAD:PANG
Average EV/EBIT: 315.9
Negative Multiple: -25.6 		N/A N/A
US
P
PerkinElmer Inc
LSE:0KHE
2 893
29%
99.8
US
Thermo Fisher Scientific Inc
NYSE:TMO
30.2
15%
2
US
Danaher Corp
NYSE:DHR
36.9
16%
2.3
CH
Lonza Group AG
SIX:LONN
37.1
22%
1.7
US
Agilent Technologies Inc
NYSE:A
27.8
24%
1.2
US
IQVIA Holdings Inc
NYSE:IQV
21.7
15%
1.4
CN
WuXi AppTec Co Ltd
SSE:603259
19.7
23%
0.9
KR
Samsung Biologics Co Ltd
KRX:207940
21.9
28%
0.8
US
Mettler-Toledo International Inc
NYSE:MTD
27.2
5%
5.4
FR
Sartorius Stedim Biotech SA
PAR:DIM
43.6
32%
1.4

See Also

Summary
PANG intrinsic value, competitors valuation, and company profile.
DCF Valuation
PANG stock valuation using Discount Cash Flow valuation method.
Relative Valuation
PANG stock valuation using valuation multiples.
Wall Street Estimates
PANG price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
PANG stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 303,700+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.